Related Experiment Video
Updated: Jul 10, 2026

Interactions with and Membrane Permeabilization of Brain Mitochondria by Amyloid Fibrils
Published on: September 28, 2019
Pathogenic role of mitochondrial [correction of mitochondral] amyloid-beta peptide
1Harvey Cushing Institutes of Neuroscience, North Shore-Long Island Jewish Health System, Great Neck, NY 11021, USA. jchen1@nshs.edu
Abstract:
Metabolic dysfunction is one of the early features in Alzheimer's disease (AD) affected brain. Amyloid-beta peptide (Abeta), a major peptide deposited in neuritic plaques, has been considered as an important initiating molecule in the pathogenesis of AD. However, the pathogenic role of Abeta remains to be determined. Here, we review current studies showing that progressive accumulation of Abeta occurs within the mitochondria of both transgenic mice overexpressing mutant Abeta peptide precursor protein and autopsied brains from AD patients. Interaction of Abeta with Abeta-binding alcohol dehydrogenase (ABAD), a short-chain alcohol dehydrogenase in the mitochondrial matrix, leads to mitochondrial dysfunction evidenced by increased reactive oxygen species generation, mitochondrial membrane permeability formation and caspase-3-like activity induction, and decreased activities of the Krebs cycle. These effects can be blocked by intracellular transduction of the ABAD decoy peptide. We hypothesize that Abeta-induced and mitochondria-dependent cytotoxic pathways might play an important role in AD pathogenesis and could be a potential therapeutic target.
Insights
Alzheimer's disease (AD) involves brain metabolic dysfunction. Amyloid-beta (Abeta) peptide accumulates in mitochondria, interacting with ABAD to cause dysfunction, a potential therapeutic target for AD.
Area of Science:
- Neuroscience
- Biochemistry
- Pathology
Background:
- Metabolic dysfunction is an early hallmark of Alzheimer's disease (AD) brain.
- Amyloid-beta peptide (Abeta) accumulation in neuritic plaques is implicated in AD pathogenesis.
- The precise pathogenic role of Abeta, particularly within mitochondria, requires further elucidation.
Purpose of the Study:
- To review the role of Abeta accumulation within mitochondria in Alzheimer's disease.
- To investigate the interaction between Abeta and mitochondrial Abeta-binding alcohol dehydrogenase (ABAD).
- To explore the potential of targeting Abeta-ABAD interaction for AD therapeutics.
Main Methods:
- Review of studies on transgenic mouse models overexpressing mutant Abeta precursor protein.
- Analysis of autopsied brain samples from Alzheimer's disease patients.
- Examination of Abeta's interaction with ABAD and its downstream effects on mitochondrial function.
Main Results:
- Progressive Abeta accumulation observed within mitochondria in both AD models and patients.
- Abeta-ABAD interaction induces mitochondrial dysfunction: increased reactive oxygen species, altered membrane permeability, and caspase-3 activation.
- Impaired Krebs cycle activity was noted as a consequence of mitochondrial dysfunction.
- ABAD decoy peptide successfully blocked Abeta-induced mitochondrial dysfunction.
Conclusions:
- Abeta-induced mitochondrial dysfunction, mediated by ABAD, is a significant factor in Alzheimer's disease pathogenesis.
- Targeting the Abeta-ABAD interaction presents a promising therapeutic strategy for Alzheimer's disease.
- Mitochondrial pathways represent a potential therapeutic target for combating AD.
Related Concept Videos
Translocation of Proteins into the Mitochondria
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Mitochondrial Precursor Proteins
Most of the mitochondrial precursors...
Mitochondrial Protein Sorting
Most of these mitochondrial proteins are encoded by the nucleus and imported to the mitochondria as unfolded or loosely folded precursors. Mitochondrial precursors...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Energy to Drive Translocation
Generally, polypeptides are unfolded by two distinct...

